Final analysis of a randomized phase II study with prednisone, vinblastine, doxorubicin, and gemcitabine in patients with early unfavorable Hodgkin lymphoma-PVAG-14 pilot.

  • Published 2014 in Clinical advances in hematology & oncology : H&O
Sorry, there's nothing here.

Cite this paper

@article{2014FinalAO, title={Final analysis of a randomized phase II study with prednisone, vinblastine, doxorubicin, and gemcitabine in patients with early unfavorable Hodgkin lymphoma-PVAG-14 pilot.}, author={}, journal={Clinical advances in hematology & oncology : H&O}, year={2014}, volume={12 8 Suppl 16}, pages={14-5} }